
1 Feb 2012
DSM Engineering Plastics invests for growth in Specialty Polyamides
DSM is to make further investments in its Kaohsiung polymerization facility in Taiwan to upgrade and develop the company’s Specialty Polyamide capabilities for its Novamid® and Akulon® Polyamide engineering plastic business. The Kaohsiung site has been a part of DSM since 2010 and already produces specialty Polyamide 6 and 6/66 materials for its Novamid product line.
Construction has already begun and the investment is expected to be completed by the last quarter of 2012. This investment is in line with DSM’s strategy of focused growth and part of the continued expansion of its Akulon® and Novamid® Polyamide product lines. It also demonstrates how DSM, as a leading supplier of engineering plastics, is committed both to Asia and to the specialty polymers market.
In May 2010 DSM added Novamid® to its portfolio through a swap deal with Mitsubishi Chemical Company. The Novamid® product line gave DSM not only a foothold in the Polyamide 6 business in the Japanese market but also added Polyamide copolymers and other specialties to the DSM Polyamide portfolio.
“These new capabilities at our Kaohsiung facility will provide a sustainable supply chain for our Polyamide specialties globally.” said Richard Pieters, Global Business Director for Polyamide at DSM.
“We are extremely committed to the polyamide business. This is crucial to our strategic intent of building a sustainable leadership position in Asia, being one of the High Growth Economies.” said Jayant Dhobley, President, DSM Engineering Plastics Asia Pacific.
The exact amount to be invested has not been disclosed.
Reader enquiries
DSM Engineering Materials
30 Pasir Panjang Road #13-31
Mapletree Business City
Singapore 117440
Singapore
Notes for editors
DSM - Bright Science. Brighter Living.™
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of over €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.
Editorial enquiries
Mirelle van der Kreeft
DSM
Inka Finne
EMG
Also available in